Stepan Company (NYSE: SCL) today reported: https://mma.prnewswire.com/media/2401084/Stepan_Company_Logo.jpg The Board of Directors of Stepan Company has approved an increase of $0.01 per share, or 2.6%, on the quarterly cash dividend on the Company's common stock. The dividend of $0.395 per share is payable on December 15, 2025, to common stockholders of record on November 28, 2025. […]
Stepan Company (NYSE: SCL) today reported: https://mma.prnewswire.com/media/2401084/Stepan_Company_Logo.jpg Third Quarter 2025 Highlights — Reported net income was $10.8 million, down 54% versus the prior year. Adjusted net income(1) was $10.9 million, down 54% versus the prior year, largely due to a higher effective tax rate and higher interest expense. — EBITDA(2) was $56.1 million and Adjusted
(NASDAQ:WULF), EASTON, Md., Oct. 29, 2025 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, low-carbon digital infrastructure, today announced that it intends to offer, subject to market conditions and other factors, $500 million aggregate principal amount of convertible senior notes due 2032 (the “Convertible
(NASDAQ:TLSA), BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced its participation as a presenting company at BIO-Europe 2025. The event, Europe's premier life sciences
(NASDAQ:OKYO), LONDON and NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, and for inflammatory eye diseases, announced that Gary S. Jacob, Ph.D., Chief Executive Officer of OKYO
(TSX-V:EVER),(OTC US:EVGUF),(Other OTC:EVGUF),(Frankfurt:5EG), TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) — Evergold Corp. (TSX-V: EVER, WKN: A2PTHZ) (“Evergold” or the “Company“) is pleased to announce that C.J. Greig Holdings Ltd., a company wholly-owned by C.J. “Charlie” Greig, a director of the Company and Evergold's Chief Exploration Officer (the “Investor“), has agreed to subscribe for up to
(TSX-V:ELBM),(NASDAQ:ELBM), TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company“) is pleased to announce the appointment of Paolo Toscano, P.Eng., as Vice President, Projects and Engineering, effective immediately. With more than three decades of experience leading large-scale mining and metals projects across North America, Mr.
(NASDAQ:ADN), LIVERMORE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in fuel cell and hydrogen technology, is accelerating the electrification of aviation through its cutting-edge high-temperature proton exchange membrane fuel cells (HT-PEM FCs). In collaboration with Stralis Aircraft and other aerospace pioneers, Advent's technology is helping enable
(NasdaqGM:USAR),(NasdaqGM:USARW), STILLWATER, Okla., Oct. 29, 2025 (GLOBE NEWSWIRE) — USA Rare Earth (Nasdaq: USAR) (USAR or the Company) today announced the appointment of Alex Moyes, PhD, as Vice President of Mining. In this role, Dr. Moyes will lead USAR's mining operations and drive the continued development and extraction planning for the Company's deposit in Round
(TSX-V:XRTX),(NASDAQ:XRTX),(Boerse Frankfurt – Freiverkehr:ANUA.F), CALGARY, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company“) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that it has closed its registered direct offering announced on